
Health and Human Services Will Allow More Waivers to IMD Exclusion From Medicaid
Health and Human Services Secretary Alex Azar announced this November

Health and Human Services Secretary Alex Azar announced this November

An often dismissed option in the struggle to address opioid

AZZLY® partner DrFirst announced recently that their Electronic Prescribing of

As the opioid epidemic in the United States continues to

On November 29th, a webinar series organized by the National

This September, the National Institute on Drug Abuse (NIDA) released

Update: On Wednesday, October 24, 2018, President Trump officially signed

AZZLY® is joining the National Association of Addiction Treatment Providers

On August 9th, Facebook announced a new policy requiring addiction

Medication-Assisted Treatment, or MAT, is revolutionizing the addiction treatment community
```html
As the opioid epidemic continues to ravage communities across the United States, the importance of effective treatment options has never been more critical. Medication-Assisted Treatment (MAT) has emerged as a vital component in the recovery process for individuals struggling with opioid use disorder. By combining medications with counseling and behavioral therapies, MAT addresses the complex nature of addiction and offers a comprehensive approach to recovery. This multifaceted strategy not only helps to alleviate withdrawal symptoms but also reduces cravings, making it easier for individuals to engage in their treatment and work towards long-term recovery.
However, as the demand for MAT increases, treatment facilities face the challenge of keeping up with the growing need for these services. The integration of technology, such as AZZLY Rize’s DrFirst tool, is helping to streamline the e-prescribing workflow and improve access to state Prescription Drug Monitoring Program (PDMP) data. This innovation is crucial for ensuring that healthcare providers can make informed decisions about patient care while navigating the complexities of opioid prescriptions. As the landscape of addiction treatment evolves, it is essential for facilities to adapt and embrace new solutions that enhance the effectiveness of Medication-Assisted Treatment.
``````html
As the opioid epidemic continues to ravage communities across the United States, the importance of effective treatment options has never been more critical. Medication-Assisted Treatment (MAT) has emerged as a vital component in the recovery process for individuals struggling with opioid use disorder. By combining medications with counseling and behavioral therapies, MAT addresses the complex nature of addiction and offers a comprehensive approach to recovery. This multifaceted strategy not only helps to alleviate withdrawal symptoms but also reduces cravings, making it easier for individuals to engage in their treatment and work towards long-term recovery.
However, as the demand for MAT increases, treatment facilities face the challenge of keeping up with the growing need for these services. The integration of technology, such as AZZLY Rize’s DrFirst tool, is helping to streamline the e-prescribing workflow and improve access to state Prescription Drug Monitoring Program (PDMP) data. This innovation is crucial for ensuring that healthcare providers can make informed decisions about patient care while navigating the complexities of opioid prescriptions. As the landscape of addiction treatment evolves, it is essential for facilities to adapt and embrace new solutions that enhance the effectiveness of Medication-Assisted Treatment.
```